Updates are available Correction dated 2021-04-01
Click to view Correction: https://doi.org/10.1186/s12955-021-01751-7
-
Authors
Varona, José Felipe
Seguí-Ripoll, José Miguel
Lozano-Duran, Cristina
Cuadrado-Gómez, Luis Miguel
Montagud-Moncho, Juan Bautista
Ramos-Guerrero, Antonio
Mirete-Ferrer, José Carlos
Donado, Esther
García-Alegría, Javier
,
-
Funding
Funding for this research was provided by:
Boehringer Ingelheim
- License Information
-
More Information
Article History
Received: 14 August 2019
Accepted: 14 September 2020
First Online: 11 December 2020
Change Date: 1 April 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12955-021-01751-7
Ethical approval
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its subsequent amendments or comparable ethical standards. According to the local legislation of observational studies, the protocol was classified by the Spanish Health Authority as an “EPA-OD: Estudio Post autorización-otros diseños” (Post-authorization study-other designs). It was also approved by the Ethics Committee of the Hospital Costa del Sol.
: Informed consent was obtained from all individual participants included in the study.
: JFV received research grants from Bayer and Pfizer. ED is an employee at Boehringer-Ingelheim Spain. JGA received research grants from Boehringer Ingelheim, Bayer, Bristol-Myers Squibb and Daiichi Sankyo. All authors received financial research support for participating in this study. The authors declare that they have no other potential competing interests.
